SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 796.55-0.6%Jan 9 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cl who wrote (94)5/8/1997 10:37:00 PM
From: Miljenko Zuanic   of 3559
 
Chuck,

Thanks for excellent cover-up of the amgn SH meeting. At the end it pay for the time. I only can fell sorry that I was not able to join you at meeting.

Regards the Ctii and their encapsulated cells, device implementation is nor by "open brain surgery" and it last for more than years, and it is easily removable or substituted with new one.

I am not saying that this method will be better than Medtronic pump, but it has to be consider as competitive alternative. Also, encapsulated cells technology is at early stage and Medtronic pump is already proved.

Regards the regn future, they have Oxokine and other research programs, which can substitute slow progress in regn-amgn collaboration. Because amgn investment in regn also suffer from recent events, their interest is also to have some good results on neuroprotective factors, where regn has better expertise than amgn (IMO).

mz
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News